Demant consensus picture on Tuesday, analysts stay cautious on the shares
23.06.2026 - 17:22:42 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 17:21.
Demant (DK0010268440) sits on Tuesday with a defined analyst consensus profile on the Copenhagen exchange. The Danish hearing care group is followed by several international houses that track the Nordic health care equipment segment, which includes peers such as GN Store Nord in Denmark and Sonova in Switzerland.
What analysts say today
According to MarketScreener’s latest Demant consensus overview, a group of covering analysts rate the stock across Buy, Hold and Sell categories, with a balanced distribution and a blended 12-month price target implying moderate upside from current levels. The company’s classification in the health care equipment & supplies sector puts it alongside GN Store Nord and global players such as Sonova, which helps international investors compare valuation and growth metrics.
The AI-based service Danelfin currently assigns Demant an AI Score of 2/10, which it labels a "Strong Sell" in terms of its probability of beating the STOXX Europe 600 over the next three months. Danelfin calculates a 41.03 percent probability of Demant outperforming the broader market, around 7.87 percentage points below the average probability of all European stocks, underscoring a cautious quantitative view despite the company’s recent share price gains.
Recent performance and sector context
Danelfin data show Demant shares have delivered a 37.90 percent gain over the past quarter, a marked move compared with the broader European health care sector. This performance follows a period where Nordic hearing care names, including GN Store Nord, benefited from stable demand for hearing aids and related solutions as elective health care activity normalized post-pandemic.
The strong quarterly return contrasts with the AI model’s weaker short-term relative performance expectation, highlighting the difference between backward-looking price performance and forward-looking quantitative indicators. For investors watching the Copenhagen-listed health care equipment names, Demant’s positioning alongside GN Store Nord and Sonova offers a clear sector benchmark for profitability, margins and innovation spending.
All news and analysis on the Demant shares
Further articles and data points on Demant, including results, consensus changes and sector comparisons, are available in the dedicated topic section and via the company’s investor relations page.
The product behind the stock
Demant’s core business is hearing health, with the group developing and selling hearing aids and related solutions under brands such as Oticon. These devices combine miniaturized hardware and signal processing software to improve speech understanding and listening comfort for people with hearing loss, complemented by audiology equipment and diagnostics services.
Where the stock trades today
The Demant shares (DK0010268440) trade on Nasdaq Copenhagen; a representative recent quote shows the stock changing hands in Danish kroner, with the latest market data indicating active trading volumes in the health care equipment segment.
Demant at a glance
- Company: Demant A/S
- ISIN: DK0010268440
- WKN: 893121
- Ticker: DEMANT
- Trading venue: Nasdaq Copenhagen
- Price (as of 2026-06-23, 17:21): [latest] DKK
- Market cap: [latest] DKK (as of 2026-06-23)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: OMX Copenhagen 25
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources believed to be reliable but may be subject to change.
